Concepedia

Hans‐Erik Wander

HW

Statistics

Publications

4

Citations

144

H-Index

4

Active since

1982

Affiliations

University of Göttingen(Current)

Hans‐Erik Wander is an author at University of Göttingen specializing in metastatic breast cancer, medicine, and breast oncology.

Publications per year

1982–1989

4

Publications

4

Hyperprolactinemia is an indicator of progressive disease and poor prognosis in advanced breast cancer

W. Holtkamp, Gerd Nagel, Hans‐Erik Wander et al. · International Journal of Cancer · 1984 · 88 citations

, , +16

Phase II study of aminoglutethimide and medroxyprogesterone acetate in the treatment of patients with advanced breast cancer.

Gerd Nagel, Hans‐Erik Wander, H.Ch. Blossey · PubMed · 1982 · 23 citations

, , +17

Phase II study with etoposide in previously untreated advanced breast cancer

Hans‐Erik Wander, W. Rauschning, Dirk Meyer et al. · Cancer Chemotherapy and Pharmacology · 1989 · 21 citations

, , +9

Aminoglutethimide and medroxyprogesterone acetate in the treatment of patients with advanced breast cancer: A phase II study of the association of medical oncology of the German cancer society (AIO)

Hans‐Erik Wander, Gerd Nagel, H.Ch. Blossey et al. · Cancer · 1986 · 12 citations

, , +17

1–4 of 4